However, increased CXCL10 abundance has also been correlated with enhanced lymph node metastasis in other models [10,27,28], whilst decreased concentrations of CXCL10 in plasma have been associated with improved progression-free and overall survival for ovarian cancer patients [11]. Here, CXCL10 is linked to metastatic malignant neoplasm in the lymph nodes.